Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers
CHENGDU, China, April 25, 2025 /PRNewswire/ — Keymed Biosciences Inc. (HKEX: 02162) ("Keymed"…